痛风发作状态与阿洛普林醇启动后患者报告的结果之间的关系
Lisa K Stamp1, Chris Frampton2, Sarah Stewart3
1University of Otago, Christchurch, Christchurch, and Health New Zealand, Te Whatu Ora Waitaha, New Zealand.
Arthritis care & research
|January 3, 2025
概括
在痛风中实现患者可接受的症状状态 (PASS) 或低疾病活性 (LDA) 是可能的. 增加的痛风发作对患者产生负面影响,强调需要有效的发作预防策略.
科学领域:
- 类风湿病学 类风湿病学
- 临床医学 临床医学
- 患者报告的结果
背景情况:
- 痛风发作是痛风的主要临床表现.
- 患者可接受的症状状态 (PASS) 和低疾病活性 (LDA) 由爆发频率来定义.
- 了解爆发状态对患者报告结果的影响对于疾病管理至关重要.
研究的目的:
- 调查痛风发作状态 (PASS,LDA,非LDA/PASS) 和患者报告的结果之间的关系.
- 评估发烧负担对痛风患者与健康相关的生活质量和疾病感知的影响.
主要方法:
- 对一项为期12个月的随机对照试验 (n=172) 的后期分析,该试验比较了胆固醇和氨醇.
- 每月收集自我报告的痛风发作.
- 评估健康评估问卷 (HAQ),EuroQol 5域 (EQ-5D-3L) 和简短的疾病感知问卷 (BIPQ) 在指定间隔.
主要成果:
- 在过去的六个月中,38%的学生获得了PASS,19%的学生获得了LDA,而43%的学生是非LDA/PASS.
- 在爆发状态和EQ-5D-3L或HAQ得分之间没有发现显著的关联.
- 发作状态和简短疾病感知问卷 (BIPQ) 的三个项目之间观察到一个显著的关联:后果,身份和关注.
结论:
- 大多数患者可以在开始服用阿洛普林醇后的六个月内达到PASS或LDA.
- 较高的痛风发作负担与对患者的负面影响增加有关.
- 优先考虑痛风发作预防对于改善患者的治疗结果和生活质量至关重要.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
196
04:49Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
77
相关概念视频
01:17Assessment of the Gastrointestinal System I: Subjective Data
143
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
143
01:11Guidelines for Writing Outcome
2.6K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.6K
01:26Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
01:24Phase II Reactions: Glucuronidation
267
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
267
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
88
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
88
01:30Peptic Ulcer Disease I: Introduction
131
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
131